Director, Medical Writing
Arlene Kray, PharmD, Ph.D., serves as Director of Medical Writing for Avenzo Therapeutics. She has over 15 years of experience in medical writing and drug development and has worked with cross-functional teams in small to large domestic and international pharmaceutical and biotech companies.
Most recently, she served as Director of Medical Writing at Dermavant Sciences, overseeing medical writing and transparency for VTAMA® (tapinarof) cream, 1%. Dr. Kray has extensive experience leading global medical writing teams across all stages of oncology drug development. Prior to Dermavant Sciences, she held roles of increasing responsibility and leadership within strategic partnerships supporting oncology development for Eli Lilly and Takeda.
Dr. Kray received her Ph.D. in Pharmacology from Vanderbilt University and her PharmD from Duquesne University.